Valuation Roche Holding AG Swiss Exchange

Equities

Market Closed - Swiss Exchange Other stock markets 18:30:03 10/04/2026 +03			5-day change	1st Jan Change
315.60 ^CHF	-0.35%		-0.75%	-3.84%

04-11	Health Care Down on Retreat from Biotech -- Health Care Roundup	DJ
04-10	Lineage Cell Therapeutics, Inc. Announces Allogeneic Cell Platform Expands into Islet Therapy for Type 1 Diabetes	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	306,810	239,812	197,073	205,191	262,098	252,527	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	-3.65%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	261,005	254,031	247,004
Change	-	-21.41%	-15.51%	3.13%	25.04%	-6.2%	-2.67%	-2.77%
P/E ratio	-	-	-	-	-	16.9x	15.7x	14.7x
PBR	-	-	-	-	-	6.01x	5.05x	4.33x
PEG	-	-	-	-	-	-	1.96x	2.2x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.02x	3.89x	3.75x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.16x	3.92x	3.67x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	10.2x	9.42x	8.64x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	11.6x	10.6x	9.81x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	16.5x	15.2x	13.6x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	6.08%	6.56%	7.35%
Dividend per Share ²	-	-	-	-	-	10.02	10.33	10.6
Rate of return	-	-	-	-	-	3.18%	3.27%	3.36%
EPS ²	-	-	-	-	-	18.63	20.12	21.47
Distribution rate	-	-	-	-	-	53.8%	51.3%	49.4%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,745	64,843	67,390
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,481	26,972	28,603
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,549	23,866	25,168
Net income ¹	13,930	12,421	11,498	8,277	12,880	15,003	15,534	17,342
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	8,479	1,504	-5,523
Reference price ²	379.10	290.50	244.50	255.50	328.20	315.60	315.60	315.60
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	2/3/22 A	2/2/23 A	2/1/24 A	1/30/25 A	1/29/26 A	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	27.6x	10.48x	21x	0.71%	841B
JOHNSON & JOHNSON	25.27x	5.88x	15.98x	2.22%	574B
ABBVIE INC.	23.1x	6.26x	12.64x	3.33%	368B
ASTRAZENECA PLC	25.82x	5.33x	14.9x	1.62%	318B
MERCK & CO., INC.	28.22x	5.02x	15.65x	2.78%	300B
NOVARTIS AG	21.36x	5.74x	13.88x	2.86%	295B
AMGEN INC.	23.42x	6.07x	10.8x	2.86%	189B
GILEAD SCIENCES, INC.	19.15x	5.87x	10.62x	2.34%	173B
NOVO NORDISK A/S	11.58x	4.13x	8.67x	4.46%	168B
Average	22.84x	6.09x	13.79x	2.57%	358.36B
Weighted average by Cap.	24.45x	6.89x	15.61x	2.16%